The cyclin D1/PRAD1 oncogene, a key regulator of the G 1 phase of the cell cycle, has been incriminated in the pathogenesis of human neoplasia. Cyclin D1 was also demonstrated to be identical to the long-sought bcl-1 oncogene in B-cell malignancies with the t(11;14)(q13;q32) translocation. We report
The PRAD-1/cyclin D1 oncogene product accumulates aberrantly in a subset of colorectal carcinomas
β Scribed by Jirina Bartkova; Jiri Lukas; Michael Strauss; Jiri Bartek
- Publisher
- John Wiley and Sons
- Year
- 1994
- Tongue
- French
- Weight
- 748 KB
- Volume
- 58
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Polymorphisms in the 2 cellβcycle control genes __Aurora A__ and __Cyclin D1__ have previously been associated with changes in the age of onset of colorectal cancer in persons harboring germline mutations in DNA mismatch repair genes associated with hereditary nonpolyposis colorectal ca
## Abstract Cyclin D1 (CCND1) and Eβcadherin (CDH1) have been shown to be important genes of the Ξ²βcatenin/LEF pathway that is involved in colorectal carcinogenesis. However, epidemiological studies on relationship between genetic variants of these two genes and colorectal cancer (CRC) have shown i